CD4 and malaria: Although our initial analysis indicated that HIV-infected women with CD4 cell counts between 200 and 500 cells/μL treated with CPT during pregnancy had a reduced risk of malaria compared to those who had been treated with SP-IPTp in earlier years, results of our sensitivity analysis suggest this finding resulted at least in part from a reduction in malaria incidence between these two time periods due to unmeasured factors.